Instrument Inactif

Communiqués Lansen Pharmaceutical Holdings Limited

Actions

503 KYG5380M1033

Produits pharmaceutiques

Communiqués

29/04/21	Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 31 MAY 2021	PU
29/04/21	Lansen Pharmaceutical : PROPOSAL FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SHARES, AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	PU
15/04/21	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
23/07/20	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
12/02/20	Lansen Pharmaceutical : CLARIFICATION ANNOUNCEMENT REVISED VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	PU
11/02/20	Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	PU
12/12/19	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
31/10/19	Lansen Pharmaceutical : RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE, AUDIT COMMITTEE AND EXECUTIVE COMMITTEE	PU
25/09/19	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
18/09/19	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
11/09/19	Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RELATION TO FIFTH SHARE REDUCTION PLAN OF STARRY	PU
10/09/19	Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	PU
10/09/19	Lansen Pharmaceutical : LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM	PU
10/09/19	Lansen Pharmaceutical : LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM	PU
14/07/16	Lansen Pharmaceutical : POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 13 JULY 2016	PU
28/06/16	Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 13 JULY 2016	PU
28/06/16	Lansen Pharmaceutical : CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARA	PU
28/06/16	Lansen Pharmaceutical : NOTICE OF EXTRAORDINARY GENERAL MEETING	PU
27/06/16	Lansen Pharmaceutical : CONNECTED AND DISCLOSABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARANTE	PU
23/06/16	Lansen Pharmaceutical : POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 June 2016	PU
15/04/16	Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 21 JUNE 2016	PU
15/04/16	Lansen Pharmaceutical : PROPOSAL FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SHARES,AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	PU
30/03/16	Lansen Pharmaceutical : LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION	PU
30/03/16	Lansen Pharmaceutical : CHANGE OF NON-EXECUTIVE DIRECTOR, EXECUTIVE DIRECTOR, AUTHORIZED REPRESENTATIVE AND MEMBER OF EXECUTIVE COMMITTEE	PU
24/03/16	Lansen Pharmaceutical : CONNECTED TRANSACTION IN RELATION TO THE EXECUTION OF A SUBSCRIPTION AGREEMENT	PU